来曲唑联合45%高脂饲料诱导生殖内分泌及代谢表型异常的多囊卵巢综合征大鼠模型研究

尹萍; 路璐; 陈媛媛; 李丽; 李赟; 童国庆

doi:10.3969/j.issn.1006-0111.2019.05.007

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

来曲唑联合45%高脂饲料诱导生殖内分泌及代谢表型异常的多囊卵巢综合征大鼠模型研究

尹萍, 路璐, 陈媛媛, 李丽, 李赟, 童国庆

文章导航 > 药学实践与服务 > 2019 > 37(5): 422-426

尹萍, 路璐, 陈媛媛, 李丽, 李赟, 童国庆. 来曲唑联合45%高脂饲料诱导生殖内分泌及代谢表型异常的多囊卵巢综合征大鼠模型研究[J]. 药学实践与服务, 2019, 37(5): 422-426. doi: 10.3969/j.issn.1006-0111.2019.05.007

引用本文:

YIN Ping, LU Lu, CHEN Yuanyuan, LI Li, LI Yun, TONG Guoqing. Effects of letrozole and 45% high-fat diet on induction of rat model of polycystic ovary syndrome with reproductive and metabolic disorder[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(5): 422-426. doi: 10.3969/j.issn.1006-0111.2019.05.007

Citation:

YIN Ping, LU Lu, CHEN Yuanyuan, LI Li, LI Yun, TONG Guoqing. Effects of letrozole and 45% high-fat diet on induction of rat model of polycystic ovary syndrome with reproductive and metabolic disorder[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(5): 422-426. doi: 10.3969/j.issn.1006-0111.2019.05.007

来曲唑联合45%高脂饲料诱导生殖内分泌及代谢表型异常的多囊卵巢综合征大鼠模型研究

doi: 10.3969/j.issn.1006-0111.2019.05.007

上海中医药大学附属曙光医院, 上海 200120

基金项目: 上海中医药大学2016年预算内项目（2016N47）

Effects of letrozole and 45% high-fat diet on induction of rat model of polycystic ovary syndrome with reproductive and metabolic disorder

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200120, China

摘要: 目的建立来曲唑联合高脂饲料诱导SD雌性大鼠多囊卵巢综合征（PCOS）内分泌及代谢异常的动物模型。方法选取18只21日龄雌性大鼠喂养45%高脂饲料16周，第6周龄开始服用来曲唑直至造模结束；8只对照组大鼠常规饲料喂养，第6周龄服用生理盐水。观察阴道涂片及卵巢组织学变化，比较每周体重变化，测定脏器重量、血清睾酮水平、糖耐量、血脂水平、空腹胰岛素以及胰岛素敏感指数。结果与对照组比较，模型组大鼠体重增加，卵巢、腹股沟脂肪质量增加，子宫、垂体质量及脏器指数显著减少。模型组大鼠卵巢呈多囊样改变，颗粒细胞层减少，白膜增加。模型组大鼠的三酰甘油和低密度脂蛋白升高，糖耐量曲线下面积增加，血清睾酮水平上升，空腹胰岛素水平升高，胰岛素敏感性降低。结论来曲唑联合高脂饲料可以建立有效的内分泌及代谢表型异常PCOS动物模型。
- 来曲唑 /
- 高脂饲料 /
- 多囊卵巢综合征 /
- 内分泌 /
- 糖脂代谢 /
- 动物模型
Abstract: Objective To establish rat polycystic ovary syndrome model with letrozole combined high fat diet. Methods Eighteen 21-day-old female rats were fed with 45% high-fat diet for 16 weeks.Letrozole was started at the 6th week of age until the end of modeling.Eight rats in control group were fed with regular diet and Saline without letrozole at the 6th week of age.The vaginal smear and ovarian histological changes were investigated.The changes in body mass,organ weight,blood testosterone level,glucose tolerance,blood lipid level,fasting insulin and insulin sensitivity index were measured. Results In the model group,the ovary of the rats showed a multi-cystic change,the granulosa cell layer decreased,and the tunica albuginea increased.Compared with the control group,the body weight of the model group increased,the weight of the ovary and inguinal fat increased,the weight and weight index of the uterus and pituitary gland decreased,the triglyceride and low density lipoprotein increased,the area under the glucose tolerance curve increased,the blood testosterone level increased,the fasting insulin increased,and the insulin sensitivity decreased. Conclusion Letrozole combined with high fat diet could establish an effective PCOS model of abnormal endocrine and metabolic phenotype.
- letrozole /
- high-fat diets /
- polycystic ovary syndrome /
- reproductive endocrine /
- glucose and lipid metabolism /
- animal model

[1]	ROSENFIELD R L,EHRMANN D A.The pathogenesis of polycystic ovary syndrome(PCOS):the hypothesis of PCOS as functional ovarian hyperandrogenism revisited[J].Endocr Rev,2016,37(5):467-520.
[2]	林莺,张宏,黄鸣清,等.来曲唑配合高脂膳食诱导胰岛素抵抗多囊卵巢综合征大鼠代谢表型的实验研究[J].中国现代医学杂志,2016,26(3):9-13.
[3]	HART R,DOHERTY D A.The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage[J].J Clin Endocrinol Metab,2015,100(3):911-919.
[4]	MORAN L J,MISSO M L,WILD R A,et al.Impaired glucose tolerance,type 2 diabetes and metabolic syndrome in polycystic ovary syndrome:a systematic review and meta-analysis[J].Human Reprod Update,2010,16(4):347-363.
[5]	李明明,潘文,康开彪,等.不同造模方法对大鼠多囊卵巢综合征伴胰岛素抵抗模型的影响[J].西部中医药,2015,28(4):11-14.
[6]	PADMANABHAN V,VEIGA-LOPEZ A.Animal models of the polycystic ovary syndrome phenotype[J].Steroids,2013,78(8):734-740.
[7]	杜丹峰,李雪莲.多囊卵巢综合征动物模型的胰岛素抵抗表现[J].国际妇产科学杂志,2013,40(1):24-26,39.
[8]	PAIXAO L,RAMOS R B,LAVARDA A,et al.Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome:a systematic review[J].Reprod Biol Endocrinol,2017,15(1):12.
[9]	PAIXAO L,RAMOS R B,LAVARDA A,et al.Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome:a systematic review[J].Reprod Biol Endocrinol,2017,15:12.
[10]	MANNERAS L,CAJANDER S,HOLMANG A,et al.A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome[J].Endocrinology,2007,148(8):3781-3791.
[11]	GOZUKARA I,DOKUYUCU R,ÖZGVR T,et al.Histopathologic and metabolic effect of ursodeoxycholic acid treatment on PCOS rat model[J].Gynecolog Endocrinol,2016,32(6):492-497.
[12]	MALIQUEO M,SUN M,JOHANSSON J,et al.Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age[J].Endocrinology,2013,154(1):434-445.
[13]	SKARRA D V,HERNANDEZ-CARRETERO A,RIVERA A J,et al.Hyperandrogenemia induced by letrozole treatment of pubertal female mice results in hyperinsulinemia prior to weight gain and insulin resistance[J].Endocrinology,2017,158(9):2988-3003.
[14]	韩静,余俊达,潘秋,等.四种高脂饲料诱发胰岛素抵抗的实验研究[J].江西中医学院学报,2010,22(4):64-66.
[15]	张涛,刘源,赵爽,等.不同高能饮食诱发胰岛素抵抗大鼠模型的比较[J].实验动物科学,2011,28(3):29-33.
[16]	RESSLER I B,GRAYSON B E,ULRICH-LAI Y M,et al.Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model[J].Am J Physiol-Endocrin Metab,2015,308(12):E1076-E1084.
[17]	朱磊,路瑛丽,冯连世,等.不同配方高脂饲料构建SD大鼠肥胖模型的实验研究[J].中国运动医学杂志,2016,35(7):642-647.
[18]	BALASUBRAMANIAN P,JAGANNATHAN L,MAHALEY R E,et al.High fat diet affects reproductive functions in female diet-induced obese and dietary resistant rats[J].J Neuroendocrinol,2012,24(5):748-755.
[19]	REZVANFAR M A,SHOJAEI SAADI H A,GOOSHE M,et al.Ovarian aging-like phenotype in the hyperandrogenism-induced murine model of polycystic ovary[J].Oxid Med Cell Longev,2014,2014:1-10.

[1]	瞿文君, 白若楠, 崔力, 周琰. 基于联合库存的公立医院多院区药品采购模式分析 . 药学实践与服务, 2024, 42(7): 315-318. doi: 10.12206/j.issn.2097-2024.202401002
[2]	舒飞, 孙蕊, 宋凯, 张元林, 闫家铭, 舒丽芯. 粉-液双室袋产品综合评估 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202312009
[3]	桂明珠, 李静, 李志玲. 儿童伏立康唑的血药浓度与CYP2C19、CYP2C9和CYP3A5基因多态性的相关性研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402020
[4]	王雪莲, 郑斯莉, 李志勇, 罗亨宇, 缪朝玉. 全身过表达人METRNL基因小鼠模型的构建与验证 . 药学实践与服务, 2024, 42(5): 198-202, 222. doi: 10.12206/j.issn.2097-2024.202311014
[5]	杨凤艳, 张月, 陈恩贤, 缪雪蓉, 魏凯. 瑞马唑仑临床应用研究进展 . 药学实践与服务, 2024, 42(9): 365-374. doi: 10.12206/j.issn.2097-2024.202405026
[6]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[7]	毛智毅, 王筱燕, 陈晓颖, 汤逸斐. 度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032
[8]	姚小静, 计佩影, 陆峰, 施国荣, 傅翔. 表面增强拉曼光谱法快速测定尿液中曲马多的研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202401072
[9]	丁千雪, 尚圣兰, 余梦辰, 余爱荣. 机器学习在肾病综合征患者他克莫司个体化用药中的应用 . 药学实践与服务, 2024, 42(6): 227-230, 243. doi: 10.12206/j.issn.2097-2024.202310007
[10]	王鹏, 陈顺, 赵逸, 高守红, 王志鹏. 卡培他滨致小鼠手足综合征模型的建立及评价 . 药学实践与服务, 2024, 42(9): 385-388, 398. doi: 10.12206/j.issn.2097-2024.202308045
[11]	杨嘉宁, 赵一颖, 肖伟. 七味脂肝方对非酒精性脂肪性肝炎动物模型的药效学评价 . 药学实践与服务, 2024, 42(9): 389-398. doi: 10.12206/j.issn.2097-2024.202404096

点击查看大图

计量

文章访问数: 4349
HTML全文浏览量: 617
PDF下载量: 360
被引次数: 0

来曲唑联合45%高脂饲料诱导生殖内分泌及代谢表型异常的多囊卵巢综合征大鼠模型研究

doi: 10.3969/j.issn.1006-0111.2019.05.007

上海中医药大学附属曙光医院, 上海 200120

基金项目: 上海中医药大学2016年预算内项目（2016N47）

收稿日期: 2018-12-15
修回日期: 2019-04-22

关键词:

来曲唑 /

内分泌 /

摘要: 目的建立来曲唑联合高脂饲料诱导SD雌性大鼠多囊卵巢综合征（PCOS）内分泌及代谢异常的动物模型。方法选取18只21日龄雌性大鼠喂养45%高脂饲料16周，第6周龄开始服用来曲唑直至造模结束；8只对照组大鼠常规饲料喂养，第6周龄服用生理盐水。观察阴道涂片及卵巢组织学变化，比较每周体重变化，测定脏器重量、血清睾酮水平、糖耐量、血脂水平、空腹胰岛素以及胰岛素敏感指数。结果与对照组比较，模型组大鼠体重增加，卵巢、腹股沟脂肪质量增加，子宫、垂体质量及脏器指数显著减少。模型组大鼠卵巢呈多囊样改变，颗粒细胞层减少，白膜增加。模型组大鼠的三酰甘油和低密度脂蛋白升高，糖耐量曲线下面积增加，血清睾酮水平上升，空腹胰岛素水平升高，胰岛素敏感性降低。结论来曲唑联合高脂饲料可以建立有效的内分泌及代谢表型异常PCOS动物模型。

English Abstract

Effects of letrozole and 45% high-fat diet on induction of rat model of polycystic ovary syndrome with reproductive and metabolic disorder

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200120, China

Received Date: 2018-12-15
Rev Recd Date: 2019-04-22

Keywords:

Abstract: Objective To establish rat polycystic ovary syndrome model with letrozole combined high fat diet. Methods Eighteen 21-day-old female rats were fed with 45% high-fat diet for 16 weeks.Letrozole was started at the 6th week of age until the end of modeling.Eight rats in control group were fed with regular diet and Saline without letrozole at the 6th week of age.The vaginal smear and ovarian histological changes were investigated.The changes in body mass,organ weight,blood testosterone level,glucose tolerance,blood lipid level,fasting insulin and insulin sensitivity index were measured. Results In the model group,the ovary of the rats showed a multi-cystic change,the granulosa cell layer decreased,and the tunica albuginea increased.Compared with the control group,the body weight of the model group increased,the weight of the ovary and inguinal fat increased,the weight and weight index of the uterus and pituitary gland decreased,the triglyceride and low density lipoprotein increased,the area under the glucose tolerance curve increased,the blood testosterone level increased,the fasting insulin increased,and the insulin sensitivity decreased. Conclusion Letrozole combined with high fat diet could establish an effective PCOS model of abnormal endocrine and metabolic phenotype.

引用本文:

Citation:

YIN Ping, LU Lu, CHEN Yuanyuan, LI Li, LI Yun, TONG Guoqing. Effects of letrozole and 45% high-fat diet on induction of rat model of polycystic ovary syndrome with reproductive and metabolic disorder[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(5): 422-426. doi: 10.3969/j.issn.1006-0111.2019.05.007